Personalized cancer vaccine stops melanoma from returning or spreading in historic trial
NEWYou can now listen to Fox News articles! An experimental skin cancer vaccine significantly reduced the risk of melanoma returning or spreading in a late-stage clinical trial from Merck and Moderna. The results mark the first positive phase 3 trial of…